These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

729 related articles for article (PubMed ID: 19362364)

  • 1. The cultivation of human multipotent mesenchymal stromal cells in clinical grade medium for bone tissue engineering.
    Pytlík R; Stehlík D; Soukup T; Kalbácová M; Rypácek F; Trc T; Mulinková K; Michnová P; Kideryová L; Zivný J; Klener P; Veselá R; Trnený M; Klener P
    Biomaterials; 2009 Jul; 30(20):3415-27. PubMed ID: 19362364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering.
    Siddappa R; Licht R; van Blitterswijk C; de Boer J
    J Orthop Res; 2007 Aug; 25(8):1029-41. PubMed ID: 17469183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced engraftment of mesenchymal stem cells in a cutaneous wound model by culture in allogenic species-specific serum and administration in fibrin constructs.
    Gregory CA; Reyes E; Whitney MJ; Spees JL
    Stem Cells; 2006 Oct; 24(10):2232-43. PubMed ID: 16763199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Xenogeneic protein free cultivation of mesenchymal multipotent stromal cells].
    Stehlík D; Pytlík R; Rychtrmocová H; Veselá R; Kopečný Z; Trč T
    Acta Chir Orthop Traumatol Cech; 2011; 78(6):537-43. PubMed ID: 22217407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro initial expansion of mesenchymal stem cells is influenced by the culture parameters used in the isolation process.
    Chen HH; Decot V; Ouyang JP; Stoltz JF; Bensoussan D; de Isla NG
    Biomed Mater Eng; 2009; 19(4-5):301-9. PubMed ID: 20042797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute.
    Bernardo ME; Avanzini MA; Perotti C; Cometa AM; Moretta A; Lenta E; Del Fante C; Novara F; de Silvestri A; Amendola G; Zuffardi O; Maccario R; Locatelli F
    J Cell Physiol; 2007 Apr; 211(1):121-30. PubMed ID: 17187344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical-scale expansion of a mixed population of bone-marrow-derived stem and progenitor cells for potential use in bone-tissue regeneration.
    Dennis JE; Esterly K; Awadallah A; Parrish CR; Poynter GM; Goltry KL
    Stem Cells; 2007 Oct; 25(10):2575-82. PubMed ID: 17585167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy.
    Haack-Sorensen M; Friis T; Bindslev L; Mortensen S; Johnsen HE; Kastrup J
    Scand J Clin Lab Invest; 2008; 68(3):192-203. PubMed ID: 17852829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of CD271(+) cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow.
    Poloni A; Maurizi G; Rosini V; Mondini E; Mancini S; Discepoli G; Biasio S; Battaglini G; Felicetti S; Berardinelli E; Serrani F; Leoni P
    Cytotherapy; 2009; 11(2):153-62. PubMed ID: 19301169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability.
    Shahdadfar A; Frønsdal K; Haug T; Reinholt FP; Brinchmann JE
    Stem Cells; 2005 Oct; 23(9):1357-66. PubMed ID: 16081661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine.
    Lange C; Cakiroglu F; Spiess AN; Cappallo-Obermann H; Dierlamm J; Zander AR
    J Cell Physiol; 2007 Oct; 213(1):18-26. PubMed ID: 17458897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue.
    Kocaoemer A; Kern S; Klüter H; Bieback K
    Stem Cells; 2007 May; 25(5):1270-8. PubMed ID: 17255520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From bone marrow to therapeutic applications: different behaviour and genetic/epigenetic stability during mesenchymal stem cell expansion in autologous and foetal bovine sera?
    Tonti GA; Mannello F
    Int J Dev Biol; 2008; 52(8):1023-32. PubMed ID: 18956335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of neuroectodermal differentiation capacity of human bone marrow stromal cells using various conversion protocols.
    Hermann A; Liebau S; Gastl R; Fickert S; Habisch HJ; Fiedler J; Schwarz J; Brenner R; Storch A
    J Neurosci Res; 2006 Jun; 83(8):1502-14. PubMed ID: 16612831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural differentiation of human mesenchymal stem cells: Evidence for expression of neural markers and eag K+ channel types.
    Mareschi K; Novara M; Rustichelli D; Ferrero I; Guido D; Carbone E; Medico E; Madon E; Vercelli A; Fagioli F
    Exp Hematol; 2006 Nov; 34(11):1563-72. PubMed ID: 17046576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells.
    Solchaga LA; Penick K; Porter JD; Goldberg VM; Caplan AI; Welter JF
    J Cell Physiol; 2005 May; 203(2):398-409. PubMed ID: 15521064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinically-feasible protocol for using human platelet lysate and mesenchymal stem cells in regenerative therapies.
    Warnke PH; Humpe A; Strunk D; Stephens S; Warnke F; Wiltfang J; Schallmoser K; Alamein M; Bourke R; Heiner P; Liu Q
    J Craniomaxillofac Surg; 2013 Mar; 41(2):153-61. PubMed ID: 22878221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovine bone- and marrow-derived progenitor cells and their potential for scaffold-based bone tissue engineering applications in vitro and in vivo.
    Reichert JC; Woodruff MA; Friis T; Quent VM; Gronthos S; Duda GN; Schütz MA; Hutmacher DW
    J Tissue Eng Regen Med; 2010 Oct; 4(7):565-76. PubMed ID: 20568083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation of mesenchymal stromal cells on mineralized collagen leads to ectopic matrix synthesis in vivo independently from prior in vitro differentiation.
    Niemeyer P; Kasten P; Simank HG; Fellenberg J; Seckinger A; Kreuz PC; Mehlhorn A; Südkamp NP; Krause U
    Cytotherapy; 2006; 8(4):354-66. PubMed ID: 16923611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy.
    Pérez-Ilzarbe M; Díez-Campelo M; Aranda P; Tabera S; Lopez T; del Cañizo C; Merino J; Moreno C; Andreu EJ; Prósper F; Pérez-Simón JA
    Transfusion; 2009 Sep; 49(9):1901-10. PubMed ID: 19497059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.